Skip to main content

Randomized Phase II Study of Everolimus (E) Versus Everolimus plus Bevacizumab (E plus B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance)

Publication ,  Journal Article
Kulke, MH; Niedzwiecki, D; Foster, NR; Fruth, B; Kunz, PL; Kennecke, H; Wolin, EM; Venook, AP
Published in: PANCREAS
March 1, 2016

Duke Scholars

Published In

PANCREAS

EISSN

1536-4828

ISSN

0885-3177

Publication Date

March 1, 2016

Volume

45

Issue

3

Start / End Page

477 / 477

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kulke, M. H., Niedzwiecki, D., Foster, N. R., Fruth, B., Kunz, P. L., Kennecke, H., … Venook, A. P. (2016). Randomized Phase II Study of Everolimus (E) Versus Everolimus plus Bevacizumab (E plus B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance). PANCREAS, 45(3), 477–477.
Kulke, Matthew H., Donna Niedzwiecki, Nathan R. Foster, Briant Fruth, Pamela L. Kunz, Hagen Kennecke, Edward M. Wolin, and Alan P. Venook. “Randomized Phase II Study of Everolimus (E) Versus Everolimus plus Bevacizumab (E plus B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance).” PANCREAS 45, no. 3 (March 1, 2016): 477–477.
Kulke MH, Niedzwiecki D, Foster NR, Fruth B, Kunz PL, Kennecke H, Wolin EM, Venook AP. Randomized Phase II Study of Everolimus (E) Versus Everolimus plus Bevacizumab (E plus B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance). PANCREAS. LIPPINCOTT WILLIAMS & WILKINS; 2016 Mar 1;45(3):477–477.

Published In

PANCREAS

EISSN

1536-4828

ISSN

0885-3177

Publication Date

March 1, 2016

Volume

45

Issue

3

Start / End Page

477 / 477

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences